Who owns Muna Therapeutics?

Muna Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital X, since 2021.

When did Sofinnova Partners acquire Muna Therapeutics?

Sofinnova Partners acquired Muna Therapeutics in 2021 (active for 5 years).

Home/Companies/Biotech/Muna Therapeutics

Muna Therapeutics

Biotech·

Denmark·Active·5yr hold

Muna Therapeutics is a healthcare / biotech company, headquartered in Denmark.

Entry

2021

Hold

5yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQDenmark

SectorHealthcare / Biotech

Danish company combining expertise in progranulin pathway biology to develop treatments for Alzheimer's disease and neurodegeneration.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings